Remote Patient Monitoring Solution for Chronic Respiratory Disease Management

NARecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

December 30, 2025

Conditions
AsthmaAsthma AttackAsthma in ChildrenAsthma AcuteAsthma Chronic
Interventions
DEVICE

AeviceMD device

The intervention group will receive the AeviceMD device on top of standard care provided by the Polyclinic. They will use the AeviceMD device for 12 weeks. They are expected to use the device for at least 5 hours at night when they are asleep. However, they can also use the device at any time of the time, based on their own preference. The AeviceMD device will provide patients with objective information of their breathing (respiratory rate) and lung sounds. This objective information can be used for participants to self-manage their asthma following the asthma action plan. During the clinical follow-up, participants can show the clinician their lung parameters, to improve clinical management

BEHAVIORAL

Standard care

All participants will receive the standard care provided by the Polyclinic. This can include a telephone follow-up by a nurse within 5 days, and follow-ups with a doctor after one week. All patients with asthma should also have an asthma action plan which provides them instructions on how to manage their asthma and the medications required when they experience symptoms. These symptoms include wheezing, chest tightness, difficulty breathing, coughing, night-waking, and symptom interfering with day-to-day activities.

Trial Locations (1)

150167

RECRUITING

SingHealth Polyclinics, Singapore

All Listed Sponsors
lead

SingHealth Polyclinics

OTHER